Advertisement

Topics

Companies Related to "Chugai Pharma Emicizumab Receives Priority Review Designation Hemophilia" [Most Relevant Company Matches] RSS

04:20 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "Chugai Pharma Emicizumab Receives Priority Review Designation Hemophilia" found in our extensive corporate database of over 50,000 company records.

Showing "Chugai Pharma Emicizumab Receives Priority Review Designation Hemophilia" Companies 1–25 of 1,400+

Extremely Relevant

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.


Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic antibody biotechnology through over-the-counter medicines to consumer healthcare products.Chugai is currently the 5th ranked pharmaceutical company in Japan in terms of sales, (the world’s second larges...

Relevant

Chugai Pharma USA, Inc.


The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963, it is a global network of patient organizations in 113 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org.

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treatment of individuals with inhibitor complications. Inspiration has a broad development portfolio, which includes advanced, clinical-stage product candidates for the treatment of hemophilia A and hemop...

Bioverativ Inc.,

Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commercialization of innovative therapies. Bioverativ is committed to actively working with the blood disorders community, and its hemophilia therapies, when launched, represented the f...

Chugai Pharmaceutical Co., Ltd

Chugai Pharmaceutical Co., Ltd. places tremendous importance on the safekeeping of personal information obtained from customers using our website (information that is personally identifiable such as your name, address, e-mail address, or phone number, and that is not otherwise publicly available). Based on our Privacy Policy the following regulations have been implemented to insure that this infor...

TI Pharma

Top Institute Pharma (TI Pharma) is a public-private partnership in which scientific and business worlds work together on groundbreaking, multidisciplinary research aimed at improving the development of socially valuable medicines. Their research portfolio is based on the disease areas as specified in Priority Medicines, a report by the World Health Organization (WHO). The knowledge gained in ...

BMM and CTMM and TI Pharma

Top Institute Pharma (TI Pharma) is a public-private partnership in which scientific and business worlds work together on groundbreaking, multidisciplinary research aimed at improving the development of socially valuable medicines. Their research portfolio is based on the disease areas as specified in Priority Medicines, a report by the World Health Organization (WHO). The knowledge gained in ...

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific i...

Bioverativ Inc. and Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific i...

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding disorders. Established in 1963, it is a global network of patient organizations in 118 countries and has official recognition from the World Health Organization. Visit WFH online at...

Bioverativ Inc.

Bioverativ (NASDAQ: BIVV) is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific innov...

Alpha Review Corporation

Alpha Review Corporation (ARC) was formed in 1995 as a medical bill review company. ARC customizes its bill review services to meet the client's individual needs by setting specific and unique customer notification parameters, providing customized management reports, and meeting any number of perhaps seemingly minor, but critical needs. This ensures a smoo...

Harvard Business Review

Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published on HBR.org, Harvard Business Review provides professionals around the world with rigorous insights and best practic...

Technology Review

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Technology Review, Inc.

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Chugai Pharmaceutical Co., Ltd.

Priority Health

Priority Health is an award-winning health benefits company recognized for its innovative solutions that improve health, lower costs and increase patient satisfaction. It provides more than 600,000 people with a broad portfolio of products, including commercial and government health plans. As a nonprofit, Priority Health has a mission to make health care o...

Chugai Pharmaceutical Company Limited

BioHealthcare Oncology

Lumos Pharma, Inc.

Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and is funded by leading healthcare investors, including Deerfield, NEA, Clarus,...

HealthFirst Financial

Founded in 2001, HealthFirst Financial is a national patient financing leader that has helped hundreds of thousands of patients afford care while improving the financial performance of healthcare organizations. HealthFirst Financial is the first and only company awarded the prestigious Peer Review Designation from the Healthcare Financial Management Associ...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and partnering with the research community to efficiently develop and bring medical innovations to market. At H3 Pharma, we highly value Inventors and share their passion for Helping Human Health

Pharma•Logic Development, Inc.

Pharma•Logic is a consulting service to the pharmaceutical, biotechnical and medical device communities. From our base in Northern California, we provide a number of services to our worldwide client base. These include review of preclinical data, strategic planning for clinical development, preparation of the IND, and development of protocols. We assist clients in the writing of final medical re...


More From BioPortfolio on "Chugai Pharma Emicizumab Receives Priority Review Designation Hemophilia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks